Black Friday is Now! Don’t miss out on up to 60% OFF InvestingProCLAIM SALE

Economic Calendar - Top 5 Things to Watch This Week

Published 10/04/2020, 07:24 AM
Updated 10/04/2020, 07:25 AM
©  Reuters
US500
-
GILD
-
IXIC
-
REGN
-

By Noreen Burke

Investing.com -- U.S. President Donald Trump remains hospitalized after being diagnosed with Covid-19 and his health will be a major factor for markets in the week ahead. Investors will also be closely following the progress of fiscal stimulus talks in Washington, amid hopes for an agreement on another aid package. A fresh round of stimulus would bolster markets which have been roiled by uncertainty ahead of the upcoming presidential election and fears that the economic recovery is running out of steam. A speech by Federal Reserve Chairman Jerome Powell on Tuesday is expected to reiterate the need for additional fiscal stimulus and the Fed will publish its latest meeting minutes a day later. Here is what you need to know to start your week.

  1. Trump’s Covid diagnosis fuels election uncertainty

Trump said Saturday that the next few days will be the "real test" of his treatment for Covid-19, after a series of contradictory messages from the White House left it unclear how ill he had become since he tested positive for the coronavirus.

Trump’s doctors said Saturday he had received the first two doses of a five-day course of Remdesivir, an intravenous antiviral drug sold by Gilead Sciences (NASDAQ:GILD). He is also taking an experimental treatment, Regeneron's (NASDAQ:REGN) REGN-COV2.

With barely a month to go until the presidential election on Nov. 3 Trump’s illness has thrown his campaign into turmoil and cast a spotlight on his handling of the pandemic. He is trailing Democratic rival Joe Biden in opinion polls.

The president has repeatedly played down the threat of the coronavirus pandemic, even as it has killed more than 208,000 Americans and ravaged the U.S. economy.

  1. Spotlight on stimulus talks intensifies

Trump’s illness has intensified the spotlight on talks in Washington aimed at reaching a new fiscal relief package.

U.S. House Speaker Nancy Pelosi said on Friday that negotiations were continuing and asked airlines to halt furloughs and firings, indicating that the House could pass a standalone bill to send aid money to airlines.

But it remains to be seen whether Trump’s diagnosis or Friday’s weaker-than-expected September jobs report will make Congress any more likely to approve a new round of stimulus amid ongoing partisan wrangling.

The slowdown in the labor market recovery is the clearest indication yet that the economy is losing momentum heading into the fourth quarter. Growth had been boosted over the summer by fiscal stimulus.

"The virus is in the driver's seat in controlling the speed of the recovery and right now the economy is in the slow lane unless Congress and the White House can settle their differences and provide additional stimulus," said Chris Rupkey, chief economist at MUFG in New York.

  1. Market volatility to remain elevated

Many investors are concerned that any deterioration in the president’s health this close to the election could roil U.S. stock markets, which recently recorded the worst monthly performance since a selloff in March.

"This injects further uncertainty into the outcome of the election," said Roberto Perli, head of global policy research at Cornerstone Macro in Washington. "My read is that markets have demonstrated an aversion of late especially to uncertainty, not so much to one or the other candidate winning."

"Markets are also paying attention to the likelihood that another stimulus package will pass soon," Perli added. "If that happens it could offset at least in part the uncertainty generated by the Covid news."

Should uncertainty persist, technology and momentum stocks that have led this year's rally may be particularly vulnerable to a selloff, some investors said. The tech-heavy Nasdaq fell more than 2% on Friday, double the S&P 500's decline.

  1. Powell speech

Fed Chairman Jerome Powell is to make a speech to the National Association of Business Economists on Tuesday where he is expected to reiterate the need for additional fiscal stimulus to underpin the slowing economic recovery.

Besides Powell, several other Fed speakers are due to deliver remarks during the week, including Chicago Fed President Charles Evans, Atlanta Fed President Raphael Bostic, New York Fed President John Williams, Minneapolis Fed President Neel Kashkari and Boston Fed President Eric Rosengren.

The Fed is also due to publish the minutes to the September FOMC meeting on Wednesday, which are expected to underline the message that there is little prospect of an interest rate hike in the next couple of years.

  1. Euro zone rescue fund squabbles

Euro zone finance ministers are to meet in Brussels on Monday to discuss implementation of a 750 billion-euro coronavirus recovery fund, widely hailed as game-changing when it was announced earlier this year. But disagreements over how the funds are to be distributed are threatening to sour the mood.

Germany is proposing that only countries who respect the rule of law could benefit from the funds amid growing alarm in the European Union about backsliding on the rule of law in Poland and Hungary. The proposal has prompted an outcry from those two countries.

Italy, Spain and Greece, whose economies are among the worst hit by the pandemic, stand to lose out from any delay in unlocking recovery funds.

--Reuters contributed to this report

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.